Ovarian cancer has historically been called a “ silent killer ,” because clinicians thought its symptoms were undetectable. Patients were often diagnosed so late that doctors thought nothing could be ...

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune ...

The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new UVA Cancer Center research ...

A new immunotherapy target called a cryptic antigen may be key in helping the immune system fight ovarian cancer.

Immunotherapy has changed the way physicians treat cancer patients. This approach to therapy targets the immune system to ...

Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...

Inspired by his close friend’s cancer journey, Nick Edwards will swim across Cook Strait in March to raise money for ovarian cancer. He speaks to the Herald’s Sarah Pollok ahead of the endeavour. A ...

Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial: San Jose, California Friday, February 21, 2025, 18:00 Hrs [IST] Anixa Bioscience ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that it, along with its partner Moffitt ...